Categories Earnings, Retail

Five Below (NASDAQ: FIVE): Q3 2019 Earnings Snapshot

— Specialty retailer Five Below (NASDAQ: FIVE) reported its third-quarter 2019 earnings of $0.18 per share versus $0.17 per share expected.

— Net sales climbed by 21% to $377.4 million versus $373.43 million expected. The growth reflects a 2.9% increase in comparable-store sales.

Five Below Q3 2019 Earnings Snapshot

— The company opened 61 new stores and ended the quarter with 894 stores in 36 states. This represents an increase in stores of 20% from the end of the third quarter of fiscal 2018.

— Looking ahead into the fourth quarter, the company expects net sales of $717-732 million, based on opening about 6 new stores and assuming a 2-3% increase in comparable sales. This is below the consensus estimates of $733.97 million.

— Net income is predicted to be in the range of $110.7-115.2 million or $1.97-2.05 per share for the fourth quarter. This is in-line with the analysts’ forecast of $2.02 per share.

— For the full year 2019, Five Below narrowed its net sales outlook to the range of $1.877-1.892 billion from the previous range of $1.872-1.892 billion. In contrast, the consensus view is $1.89 billion.

— The net sales guidance for the full year is based on opening 150 new stores and assuming an approximate 2.5% increase in comparable sales.

— For the full year, net income guidance is tightened to the range of $175.4-179.9 million or $3.11-3.19 per share from the previous range of $173.4-179.9 million or $3.08-3.19 per share. This is compared to the Street’s view of $3.15 per share.

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top